Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma

American Journal of Pathology

Volumn 180, Issue 4, 2012, Pages 1653-1662

  Shiba Ishii, Aya ^a   Noguchi, Masayuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; STRATIFIN; TRICHOSTATIN A;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; DEMETHYLATION; DISEASE ASSOCIATION; DNA METHYLATION; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR CELL;

14-3-3 PROTEINS; ADENOCARCINOMA; BASE SEQUENCE; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; EXONUCLEASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; LUNG; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM STAGING; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84859106601     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.12.014     Document Type: Article

References (55)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. M. Noguchi, A. Morikawa, M. Kawasaki, Y. Matsuno, T. Yamada, S. Hirohashi, H. Kondo, Y. Shimosato Small adenocarcinoma of the lung Histologic characteristics and prognosis Cancer 75 1995 2844 2852
3. A. Shiba-Ishii, J. Kano, Y. Morishita, Y. Sato, Y. Minami, M. Noguchi High expression of stratifin is a universal abnormality during the course of malignant progression of early-stage lung adenocarcinoma Int J Cancer 129 2011 2445 2453
4. M.K. Dougherty, D.K. Morrison Unlocking the code of 14-3-3 J Cell Sci 117 2004 1875 1884
5. H. Fu, R.R. Subramanian, S.C. Masters 14-3-3 proteins: structure, function, and regulation Annu Rev Pharmacol Toxicol 40 2000 617 647
6. H. Hermeking The 14-3-3 cancer connection Nat Rev Cancer 3 2003 931 943
7. H. Hermeking, C. Lengauer, K. Polyak, T.C. He, L. Zhang, S. Thiagalingam, K.W. Kinzler, B. Vogelstein 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression Mol Cell 1 1997 3 11
8. T.A. Chan, H. Hermeking, C. Lengauer, K.W. Kinzler, B. Vogelstein 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage Nature 401 1999 616 620
9. C. Laronga, H.Y. Yang, C. Neal, M.H. Lee Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression J Biol Chem 275 2000 23106 23112
10. E. Dellambra, O. Golisano, S. Bondanza, E. Siviero, P. Lacal, M. Molinari, S. D'Atri, M. De Luca Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes J Cell Biol 149 2000 1117 1130
11. C.B. Umbricht, E. Evron, E. Gabrielson, A. Ferguson, J. Marks, S. Sukumar Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer Oncogene 20 2001 3348 3353
12. A.T. Ferguson, E. Evron, C.B. Umbricht, T.K. Pandita, T.A. Chan, H. Hermeking, J.R. Marks, A.R. Lambers, P.A. Futreal, M.R. Stampfer, S. Sukumar High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer Proc Natl Acad Sci U S A 97 2000 6049 6054
13. M. Gasco, A.K. Bell, V. Heath, A. Sullivan, P. Smith, L. Hiller, I. Yulug, G. Numico, M. Merlano, P.J. Farrell, M. Tavassoli, B. Gusterson, T. Crook Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity Cancer Res 62 2002 2072 2076
14. N. Iwata, H. Yamamoto, S. Sasaki, F. Itoh, H. Suzuki, T. Kikuchi, H. Kaneto, S. Iku, I. Ozeki, Y. Karino, T. Satoh, J. Toyota, M. Satoh, T. Endo, K. Imai Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma Oncogene 19 2000 5298 5302
15. D. Lodygin, J. Diebold, H. Hermeking Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression Oncogene 23 2004 9034 9041
16. H. Suzuki, F. Itoh, M. Toyota, T. Kikuchi, H. Kakiuchi, K. Imai Inactivation of the 14-3-3 sigma gene is associated with 5′ CpG island hypermethylation in human cancers Cancer Res 60 2000 4353 4357
17. T. Urano, T. Saito, T. Tsukui, M. Fujita, T. Hosoi, M. Muramatsu, Y. Ouchi, S. Inoue Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth Nature 417 2002 871 875
18. K. Nakanishi, S. Hashizume, M. Kato, T. Honjoh, Y. Setoguchi, K. Yasumoto Elevated expression levels of the 14-3-3 family of proteins in lung cancer tissues Hum Antibodies 8 1997 189 194
19. J.M. Moreira, G. Ohlsson, F.E. Rank, J.E. Celis Down-regulation of the tumor suppressor protein 14-3-3sigma is a sporadic event in cancer of the breast Mol Cell Proteomics 4 2005 555 569
20. M. Ide, T. Nakajima, T. Asao, H. Kuwano Inactivation of 14-3-3sigma by hypermethylation is a rare event in colorectal cancers and its expression may correlate with cell cycle maintenance at the invasion front Cancer Lett 207 2004 241 249
21. D.B. Villaret, T. Wang, D. Dillon, J. Xu, D. Sivam, M.A. Cheever, S.G. Reed Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis Laryngoscope 110 2000 374 381
22. K. Shimomura, C. Sakakura, Y. Fujita, M. Nakanishi, A. Hagiwara, H. Yamagishi [Overexpression of 14-3-3 in primary gastric cancers and clinical application for the detection of micrometastases in the peritoneal cavity] Nippon Geka Gakkai Zasshi 103 2002 386
23. H. Friess, J. Ding, J. Kleeff, L. Fenkell, J.A. Rosinski, A. Guweidhi, J.F. Reidhaar-Olson, M. Korc, J. Hammer, M.W. Buchler Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer Cell Mol Life Sci 60 2003 1180 1199
24. C.A. Iacobuzio-Donahue, R. Ashfaq, A. Maitra, N.V. Adsay, G.L. Shen-Ong, K. Berg, M.A. Hollingsworth, J.L. Cameron, C.J. Yeo, S.E. Kern, M. Goggins, R.H. Hruban Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies Cancer Res 63 2003 8614 8622
25. C.D. Logsdon, D.M. Simeone, C. Binkley, T. Arumugam, J.K. Greenson, T.J. Giordano, D.E. Misek, R. Kuick, S. Hanash Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer Cancer Res 63 2003 2649 2657
26. A. Perathoner, D. Pirkebner, G. Brandacher, G. Spizzo, S. Stadlmann, P. Obrist, R. Margreiter, A. Amberger 14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients Clin Cancer Res 11 2005 3274 3279
27. Y. Zhang, M. Karas, H. Zhao, S. Yakar, D. LeRoith 14-3-3sigma mediation of cell cycle progression is p53-independent in response to insulin-like growth factor-I receptor activation J Biol Chem 279 2004 34353 34360
28. H. Osada, Y. Tatematsu, Y. Yatabe, T. Nakagawa, H. Konishi, T. Harano, E. Tezel, M. Takada, T. Takahashi Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers Oncogene 21 2002 2418 2424
29. M. Ehrlich DNA methylation in cancer: too much, but also too little Oncogene 21 2002 5400 5413
30. J. Frigola, X. Sole, M.F. Paz, V. Moreno, M. Esteller, G. Capella, M.A. Peinado Differential DNA hypermethylation and hypomethylation signatures in colorectal cancer Hum Mol Genet 14 2005 319 326
31. A.V. Bazhin, C. De Smet, M.O. Golovastova, J. Schmidt, P.P. Philippov Aberrant demethylation of the recoverin gene is involved in the aberrant expression of recoverin in cancer cells Exp Dermatol 19 2010 1023 1025
32. J. Kano, T. Ishiyama, T. Iijima, Y. Morishita, S. Murata, K. Hisakura, N. Ohkohchi, M. Noguchi Differentially expressed genes in a porcine adult hepatic stem-like cell line and their expression in developing and regenerating liver Lab Invest 88 2008 132 143
33. B. Iacopetta, F. Grieu, M. Phillips, A. Ruszkiewicz, J. Moore, T. Minamoto, K. Kawakami Methylation levels of LINE-1 repeats and CpG island loci are inversely related in normal colonic mucosa Cancer Sci 98 2007 1454 1460
34. E. Smith, T. Bianco-Miotto, P. Drew, D. Watson Method for optimizing methylation-specific PCR Biotechniques 35 2003 32 33
35. Y. Anami, T. Iijima, K. Suzuki, J. Yokota, Y. Minami, H. Kobayashi, K. Satomi, Y. Nakazato, M. Okada, M. Noguchi Bronchioloalveolar carcinoma (lepidic growth) component is a more useful prognostic factor than lymph node metastasis J Thorac Oncol 4 2009 951 958
36. D. Takai, P.A. Jones The CpG island searcher: a new WWW resource In Silico Biol 3 2003 235 240
37. K. Hibi, M. Sakata, Y.H. Kitamura, K. Sakuraba, A. Shirahata, T. Goto, H. Mizukami, M. Saito, K. Ishibashi, G. Kigawa, H. Nemoto, Y. Sanada Demethylation of the CD133 gene is frequently detected in advanced colorectal cancer Anticancer Res 29 2009 2235 2237
38. L.M. Kong, C.G. Liao, L. Chen, H.S. Yang, S.H. Zhang, Z. Zhang, H.J. Bian, J.L. Xing, Z.N. Chen Promoter hypomethylation up-regulates CD147 expression through increasing Sp1 binding and associates with poor prognosis in human hepatocellular carcinoma J Cell Mol Med 15 2011 1415 1428
39. Q. Ye, B. Feng, Y.F. Peng, Q. Cai, X.H. Chen, B.Q. Yu, J.J. Ma, A.G. Lu, J.W. Li, M.L. Wang, B.Y. Liu, M.H. Zheng Demethylation of the gamma-synuclein gene CpG island in colorectal cancer and its clinical significance Zhonghua Wei Chang Wai Ke Za Zhi 13 2010 440 444
40. U.K. Bhawal, K. Tsukinoki, T. Sasahira, F. Sato, Y. Mori, N. Muto, M. Sugiyama, H. Kuniyasu Methylation and intratumoural heterogeneity of 14-3-3 sigma in oral cancer Oncol Rep 18 2007 817 824
41. M. Gasco, A. Sullivan, C. Repellin, L. Brooks, P.J. Farrell, J.A. Tidy, B. Dunne, B. Gusterson, D.J. Evans, T. Crook Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia Oncogene 21 2002 1876 1881
42. M. Esteller, J.G. Herman Cancer as an epigenetic disease: dNA methylation and chromatin alterations in human tumours J Pathol 196 2002 1 7
43. H. Wu, Y. Chen, J. Liang, B. Shi, G. Wu, Y. Zhang, D. Wang, R. Li, X. Yi, H. Zhang, L. Sun, Y. Shang Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis Nature 438 2005 981 987
44. H.J. Jun, S. Woolfenden, S. Coven, K. Lane, R. Bronson, D. Housman, A. Charest Epigenetic regulation of c-ROS receptor tyrosine kinase expression in malignant gliomas Cancer Res 69 2009 2180 2184
45. L. Cui, L.Y. Xu, Z.Y. Shen, Q. Tao, S.Y. Gao, Z. Lv, Z.P. Du, W.K. Fang, E.M. Li NGALR is overexpressed and regulated by hypomethylation in esophageal squamous cell carcinoma Clin Cancer Res 14 2008 7674 7681
46. C. De Smet, A. Loriot DNA hypomethylation in cancer: epigenetic scars of a neoplastic journey Epigenetics 5 2011 206 213
47. J. Roman-Gomez, A. Jimenez-Velasco, X. Agirre, J.A. Castillejo, G. Navarro, E. San Jose-Eneriz, L. Garate, L. Cordeu, F. Cervantes, F. Prosper, A. Heiniger, A. Torres Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia Leuk Res 32 2008 487 490
48. L. Menendez, B.B. Benigno, J.F. McDonald L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas Mol Cancer 3 2004 12 16
49. K. Saito, K. Kawakami, I. Matsumoto, M. Oda, G. Watanabe, T. Minamoto Long interspersed nuclear element 1 hypomethylation is a marker of poor prognosis in stage IA non-small cell lung cancer Clin Cancer Res 16 2010 2418 2426
50. M. Esteller Epigenetics in cancer N Engl J Med 358 2008 1148 1159
51. S.E. Goelz, B. Vogelstein, S.R. Hamilton, A.P. Feinberg Hypomethylation of DNA from benign and malignant human colon neoplasms Science 228 1985 187 190
52. A.P. Feinberg Alterations in DNA methylation in colorectal polyps and cancer Prog Clin Biol Res 279 1988 309 317
53. A.P. Feinberg, C.W. Gehrke, K.C. Kuo, M. Ehrlich Reduced genomic 5-methylcytosine content in human colonic neoplasia Cancer Res 48 1988 1159 1161
54. A.V. Bazhin, C. De Smet, M.O. Golovastova, J. Schmidt, P.P. Philippov Aberrant demethylation of the recoverin gene is involved in the aberrant expression of recoverin in cancer cells Exp Dermatol 19 2011 1023 1025
55. J.F. Costello, M.C. Fruhwald, D.J. Smiraglia, L.J. Rush, G.P. Robertson, X. Gao, F.A. Wright, J.D. Feramisco, P. Peltomaki, J.C. Lang, D.E. Schuller, L. Yu, C.D. Bloomfield, M.A. Caligiuri, A. Yates, R. Nishikawa, H. Su Huang, N.J. Petrelli, X. Zhang, M.S. O'Dorisio, W.A. Held, W.K. Cavenee, C. Plass Aberrant CpG-island methylation has non-random and tumour-type-specific patterns Nat Genet 24 2000 132 138